Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
The world is dealing with a global pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19), which is the illness caused by SARS-CoV-2, is overwhelming healthcare systems around the world. Although the main clinical manifestations of COVID-19 are respirato...
Guardado en:
Autores principales: | Mahmoud Abdelnabi, Nouran Eshak, Yehia Saleh, Abdallah Almaghraby |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d9f509770f646b9a6755fe84b74e965 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
por: Mahmoud Abdelnabi, et al.
Publicado: (2020) -
Ivabradine and AF: Coincidence, Correlation or a New Treatment?
por: Mahmoud Abdelnabi, et al.
Publicado: (2020) -
Acute myocarditis after coronavirus disease 2019 vaccination
por: Beuy Joob, et al.
Publicado: (2021) -
Coronavirus Disease 2019 and Catheterisation Laboratory Considerations: “Looking for Essentials”
por: Syed Haseeb Raza Naqvi, et al.
Publicado: (2020) -
Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications
por: Chia Siang Kow, et al.
Publicado: (2020)